Recruiting Ulcerative Colitis Studies in Richmond
Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors
The study regimen will be administered on an outpatient basis and all medications are administered intravenously (IV). Subjects will receive treatment on Day 1 and Day 15 of each 28-day cycle consisti...
NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
This is a Phase 2, open-label, multi-center, 2-part study of NS-089/NCNP-02 administered by weekly IV infusion to ambulant boys aged ≥4 to \<15 years with DMD due to mutations amenable to exon 44 skip...
About Ulcerative Colitis Clinical Trials in Richmond
Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.
There are currently 2 ulcerative colitis clinical trials recruiting participants in Richmond, VA. These studies are seeking a combined 56 participants. Research is being sponsored by Tiago Biachi de Castria, NS Pharma, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ulcerative Colitis Clinical Trials in Richmond — FAQ
Are there ulcerative colitis clinical trials in Richmond?
Yes, there are 2 ulcerative colitis clinical trials currently recruiting in Richmond, VA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Richmond?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Richmond research site will contact you about next steps.
Are clinical trials in Richmond free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Richmond studies also compensate for your time and travel.
What ulcerative colitis treatments are being tested?
The 2 active trials in Richmond are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.
Data updated March 2, 2026 from ClinicalTrials.gov